Advertisement

Topics

Cancer Corporate

13:11 EST 18th December 2018 | BioPortfolio

Propanc Biopharma, Inc.

Propanc Biopharma, Inc. (the "Company") is a biopharmaceutical company developing new cancer treatments initially for patients suffering from pancreatic, ovarian and colorectal cancers. The Company has developed a formulation of anti-cancer compounds, which exert a number of effects designed to control or prevent tumors from recurring and spreading through...

OncoImmunity

OncoImmunity is a machine-learning company offering a proprietary technology to address the key knowledge gaps in the prediction of bone fide immunogenic neoantigens for personalized cancer immunotherapy. OncoImmunity's software facilitates effective patient selection for cancer immunotherapy, and identifies optimal neoantigen targets for truly personal...

Ayala Pharmaceuticals, Inc.

Ayala Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to developing targeted cancer therapies for people living with genetically defined cancers. Ayala is broadly developing its product candidates, AL101 and AL102, best-in-class gamma secretase inhibitors, with clinical and nonclinical studies underway in both solid tumors (AL...

Seer, Inc.

Seer is a life sciences and health data company focused on capturing and translating molecular insights from the proteome to enable early, pre-symptomatic detection of cancer and neurological diseases, drive earlier treatment, and improve patient outcomes. Based in South San Francisco, CA, Seer’s novel Proteograph™ platform allows for the first-e...

Atlanta Gastroenterology Associates

Founded in 1976, Atlanta Gastroenterology Associates (AGA) is one of the largest gastroenterology practices in the country dedicated to the detection and treatment of digestive and liver diseases, as well as colon cancer. With offices located throughout Metro Atlanta and North Georgia – including seven pediatric offices – its board-certified phys...

California Breast Cancer Research Program

Tvardi Therapeutics Inc.

Tvardi is a privately held, clinical-stage biopharmaceutical company headquartered in Houston, Texas. The company was founded in 2017 by Drs. David Tweardy and Ron DePinho and is focused on the development of STAT3 inhibitors. STAT3 is a key signaling molecule positioned at the intersection of many signaling pathways controlling gene networks integral to t...

Checkmate Pharmaceuticals Inc.

Checkmate Pharmaceuticals is a clinical stage company that is leveraging its expertise in the field of CpG oligonucleotides to discover and develop immunotherapies designed to increase the efficacy of existing immunotherapies and to provide new treatment options for patients and their healthcare providers. Checkmate’s lead product candidate, CMP-001, ...

Black Diamond Therapeutics

Black Diamond Therapeutics is a next-wave cancer precision medicine company. Black Diamond pioneered the development of selective medicines for patients with genetically defined cancers driven by oncogenes activated by allosteric mutations. Using its MAP platform, Black Diamond is uncovering new ways to functionally assess the mutational landscape of indiv...

Central Ohio Urology Group

Central Ohio Urology Group is a leading provider of urological services with a network of more than 18 locations throughout Ohio. Headquartered just outside of Columbus in Gahanna, Ohio, COUG provides a comprehensive suite of urological services, including general urology, advanced treatment options for bladder and prostate cancer, and radiation oncology. ...

BryoLogyx

BryoLogyx is developing a new class of drugs to enhance the response rates and treatment durability of cancer immunotherapies and anti-HIV agents. The company’s initial focus is on cancer, where it capitalizing on two recent scientific advances: the discovery that a complex natural product, bryostatin, stimulates tumor antigen production to amplify the ...

Iterion Therapeutics

Iterion Therapeutics is a venture-backed, clinical stage biotechnology company developing novel targeted cancer therapeutics. The company’s lead product, Tegavivint, is a potent and selective inhibitor of the Wnt/b-catenin signaling pathway, implicated in cell proliferation, differentiation, immune evasion and stem cell renewal. Tegavivint demonstrate...

Triumvira Immunologics Inc.

Triumvira Immunologics, Inc. is an immunotherapy company co-founded in 2015 by Dr. Jonathan Bramson at McMaster University and Bloom Burton & Co., a niche life-sciences investment bank, with the vision of developing novel T cell therapies that are safer and more efficacious than current cell therapy cancer treatments, including chimeric antigen receptor (C...

CMO Consulting, Inc.

CMO Consulting is led by Edward Garmey, M.D. a former academic hematologist-oncologist at Memorial Sloan-Kettering Cancer Center with a successful industry track-record comprising over a decade of senior leadership experience including seven prior CMO roles. CMO Consulting provides its clients, ranging from blue-chip venture capital firms to start-ups and ...

Immunochina

Immunochina is committed to the development of CAR-T technology and CAR-T cell products for the treatment of malignant tumors. Founders of Immunochina, Dr. Ting He, Dr. Xin'an Lu and Dr. Feifei Qi, graduated from School of Life Sciences, Tsinghua University. They have been devoted to the basic and translational research in cancer and immunology, and have m...

Onco360 Oncology Pharmacy

Onco360 is the largest independent Oncology Pharmacy and clinical support services company in the country. Onco360 was founded in 2003 to bring together the stakeholders involved in the cancer treatment process and serve the specialized needs of oncologists, patients, hospitals, cancer centers of excellence, manufacturers, health plans, and payers. It disp...

Turning Point Therapeutics, Inc.

Turning Point Therapeutics is a clinical-stage precision oncology company forging a new path for targeted cancer care. Founded in October 2013 by Dr. J. Jean Cui, the lead inventor of Pfizer’s oncology drugs crizotinib and lorlatinib, the company is developing a pipeline of novel drugs that aim to tackle treatment resistance and give new hope to patie...

Oncorus, Inc.

At Oncorus, we are driving innovation to deliver next-generation, best-in-class oncolytic viral therapies to transform outcomes for cancer patients. We are advancing a portfolio of locally and systemically administered oncolytic virus therapies for a broad spectrum of indications with significant unmet needs based on our oncolytic herpes simplex virus (oHS...

TransMed Systems, Inc.

TransMed is a leading provider of technology, insights, and expertise that help harness the power of knowledge to dramatically improve the process of developing, identifying, and matching eligible patients to clinical trials. Powered by a vast oncology data consortium, a powerful clinical trial enablement platform, and people expertise, TransMed believes t...

Rainier Therapeutics, Inc.

Rainier Therapeutics, Inc. is a privately-held, clinical stage biotechnology company developing a targeted biologic for the potential treatment of metastatic and early stage bladder cancer, an area of high unmet need. The company’s antibody, vofatamab (B-701) is focused specifically on the fibroblast growth factor receptor 3 (FGFR3), a known driver of...

Spirita Oncology, LLC

Spirita Oncology is an integrated oncology research and development company with experience in developing, managing and optimizing global pharmaceutical drug development programs from late discovery, translational research and clinical development through market authorization and post-marketing life-cycle management.

Forbius

Forbius is a clinical stage company that designs and develops biotherapeutics for the treatment of cancer and fibrotic diseases. Forbius’ medicines are designed to radically transform patients’ lives. We use our strength in biological understanding and diverse protein engineering technologies to design superior inhibitors of validated pathways. W...

ImpediMed

Lymphedema is a condition that can cause significant swelling of the upper and lower extremities due to the build-up of excess lymph fluid. This can occur when the lymphatic system, which is responsible for draining excess fluid from the body and is a key component of the immune system, is damaged or altered. In breast cancer patients, this can occur after surgery, such as removal or biopsy o...

HOOKIPA Pharma Inc

HOOKIPA Pharma Inc. is a clinical stage company developing medicines designed to prevent and potentially cure infectious diseases and cancer. With this goal in mind, we created proprietary technologies to reprogram and stimulate the immune system.

AsclepiX Therapeutics, Inc.

AsclepiX Therapeutics is transforming the treatment of ocular diseases and cancer with a singular focus on a novel peptide platform with the power to inhibit and potentially even reverse disease progression. The mechanism of action of AXT107 targets multiple pathways, including vascular endothelial growth factor A (VEGF-A) and Tie2, two factors that promot...

Advertisement
Quick Search
Advertisement
Advertisement

 

review and buy Cancer market research data and corporate reports here